Used in pharmaceutical research as a chiral intermediate for the synthesis of central nervous system (CNS) active compounds. Its structural features make it suitable for developing agents targeting neurological disorders, particularly those involving receptor modulation such as dopamine or serotonin receptors. The compound’s stereochemistry and rigid framework enhance selectivity and binding affinity in drug candidates. It is also employed in asymmetric synthesis and catalysis due to its oxazoline core, supporting the development of enantiomerically pure therapeutics.